D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Alibaba
BABA
|
+$655M |
| 2 |
NVIDIA
NVDA
|
+$579M |
| 3 |
Amazon
AMZN
|
+$425M |
| 4 |
ConocoPhillips
COP
|
+$423M |
| 5 |
Johnson & Johnson
JNJ
|
+$380M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$868M |
| 2 |
Meta Platforms (Facebook)
META
|
+$554M |
| 3 |
Apple
AAPL
|
+$461M |
| 4 |
CELG
Celgene Corp
CELG
|
+$339M |
| 5 |
Pfizer
PFE
|
+$316M |
Sector Composition
| 1 | Technology | 19.2% |
| 2 | Consumer Discretionary | 16.83% |
| 3 | Healthcare | 16.01% |
| 4 | Industrials | 8.99% |
| 5 | Financials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
RB Global
RBA
$22B
| $10.7M | 0.01% |
321,730
-14,608
| -4% | -$485K |
|
802
Accuray
ARAY
$175M
| $10.7M | 0.01% |
2,755,925
+384,714
| +16% | +$1.49M |
|
|
SGEN
803
DELISTED
Seagen Inc. Common Stock
SGEN
| $10.7M | 0.01% |
154,081
+45,898
| +42% | +$3.18M |
|
804
ATI
ATI
$10.5B
| $10.7M | 0.01% |
423,067
-40,487
| -9% | -$1.02M |
|
|
DRE
805
DELISTED
Duke Realty Corp.
DRE
| $10.6M | 0.01% |
334,628
+324,247
| +3,123% | +$10.2M |
|
806
Avanos Medical
AVNS
$576M
| $10.5M | 0.01% |
241,338
-146,265
| -38% | -$6.38M |
|
807
SPX Corp
SPXC
$9.29B
| $10.5M | 0.01% |
316,798
-135,889
| -30% | -$4.49M |
|
808
Haemonetics
HAE
$2.59B
| $10.5M | 0.01% |
86,852
-183,756
| -68% | -$22.1M |
|
|
WCG
809
DELISTED
Wellcare Health Plans, Inc.
WCG
| $10.4M | 0.01% |
36,609
-9,273
| -20% | -$2.64M |
|
|
CHX
810
DELISTED
ChampionX
CHX
| $10.4M | 0.01% |
310,455
+201,664
| +185% | +$6.76M |
|
811
Taylor Morrison
TMHC
$6.89B
| $10.4M | 0.01% |
496,745
-172,772
| -26% | -$3.62M |
|
812
Deckers Outdoor
DECK
$16.9B
| $10.4M | 0.01% |
354,876
-92,106
| -21% | -$2.7M |
|
813
CBIZ
CBZ
$3.01B
| $10.4M | 0.01% |
530,504
+61,167
| +13% | +$1.2M |
|
814
Grand Canyon Education
LOPE
$5.69B
| $10.4M | 0.01% |
88,699
-167,418
| -65% | -$19.6M |
|
|
BHVN
815
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $10.4M | 0.01% |
236,916
+197,879
| +507% | +$8.66M |
|
816
Marsh & McLennan
MMC
$97.7B
| $10.4M | 0.01% |
103,790
+62,463
| +151% | +$6.23M |
|
817
Adtran
ADTN
$849M
| $10.3M | 0.01% |
678,228
+248,296
| +58% | +$3.79M |
|
818
COPT Defense Properties
CDP
$3.45B
| $10.3M | 0.01% |
391,122
-175,808
| -31% | -$4.64M |
|
819
V2X
VVX
$1.73B
| $10.2M | 0.01% |
251,955
-14,406
| -5% | -$584K |
|
|
AMAG
820
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $10.2M | 0.01% |
1,022,054
-15,705
| -2% | -$157K |
|
821
Charter Communications
CHTR
$35.9B
| $10.2M | 0.01% |
25,787
+2,130
| +9% | +$842K |
|
822
Belden
BDC
$5.15B
| $10.2M | 0.01% |
170,898
-9,250
| -5% | -$551K |
|
|
SIVB
823
DELISTED
SVB Financial Group
SIVB
| $10.2M | 0.01% |
45,292
-58,636
| -56% | -$13.2M |
|
824
Stitch Fix
SFIX
$745M
| $10.2M | 0.01% |
317,892
-391,072
| -55% | -$12.5M |
|
|
PDCE
825
DELISTED
PDC Energy, Inc.
PDCE
| $10.2M | 0.01% |
281,714
+240,717
| +587% | +$8.68M |
|